Vnitr Lek 2023, 69(5):299-304 | DOI: 10.36290/vnl.2023.059

Acute kidney injury in patients with cirrhosis - practical summary

Kateřina Množil Střídová1, Soňa Fraňková2, Jan Šperl2
1 Interní klinika FNKV a 3. LF UK, Praha
2 Klinika hepatogastroenterologie, Institut klinické a experimentální medicíny, Praha

Acute kidney injury (AKI) is a relatively common condition in patients with advanced liver disease and which is associated with increased mortality. It mainly affects patients with decompensated cirrhosis, particularly those with advanced portal hypertension and ascites. The dual organ involvement may have different forms. The contributing pathogenetic mechanisms are common and predict a dismal prognosis. Early diagnosis and interventions involving specialists (in particular, hepatologists and nephrologists) are essential to improve outcomes.

Keywords: acute kidney injury, hepatorenal syndrome, liver cirrhosis, therapy.

Accepted: August 24, 2023; Published: September 12, 2023  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Střídová KM, Fraňková S, Šperl J. Acute kidney injury in patients with cirrhosis - practical summary. Vnitr Lek. 2023;69(5):299-304. doi: 10.36290/vnl.2023.059.
Download citation

References

  1. Teplan V. Posuzování funkce ledvin u pacientů s jaterním onemocněním. Gastroent Hepatol. 2021; 75(2):138-142. Go to original source...
  2. Merta M. Renální komplikace akutních a chronických onemocnění jater. Gastroent Hepatol. 2019;73(3):250-256. Go to original source...
  3. Krátká K, Libicherová P, Tesař V, et al. Doporučené postupy ČNS a ČHS JEP pro diagnostiku a léčbu akutního poškození ledvin u jaterní cirhozy. Aktuality v nefrologii. 2021;27(1):7-14.
  4. Gupta K, Bhurwal A, Law C, et al. Acute kidney injury and hepatorenal syndrome in cirrhosis. World J Gastroenterol. 2021 July 14;27(26):3984-4003. Go to original source... Go to PubMed...
  5. Sanyal AJ, Boyer TD, Terrault NA, et al. Zakim and Boyer's hepatology. 7th ed. Elsevier - Health Sciences Division: 2016: 262-280. ISBN 9780323375917
  6. Bera C, Wong F. Management of hepatorenal syndrome in liver cirrhosis: a recent update. Therap Adv Gastroenterol. 2022;15:17562848221102679 Go to original source... Go to PubMed...
  7. European Association for the Study of the Liver. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. Journal of Hepatology. 2018;69:406-460. Go to original source... Go to PubMed...
  8. Flamm SL, Brown K, Wadei HM, et al. The Current Management of Hepatorenal Syndrome - Acute Kidney Injury in the United States and the Potential of Terlipressin. Liver Transpl. 2021 Aug;27(8):1191-1202. Go to original source... Go to PubMed...
  9. Sanchez LO, Francoz C. Global strategy for the diagnosis and management of acute kidney injury in patients with liver cirrhosis. United European Gastroenterol J. 2021 Mar; 9(2):220-228 Go to original source... Go to PubMed...
  10. Chancharoenthana W, Leelahavanichkul A. Acute kidney injury spectrum in patients with chronic liver disease: Where do we stand? World J Gastroenterol. 2019 July 28; 25(28):3684-3703. Go to original source... Go to PubMed...
  11. Møller S, Bendtsen F. The pathophysiology of arterial vasodilatation and hyperdynamic circulation in cirrhosis. Liver International. 2018;38:570-580. Go to original source... Go to PubMed...
  12. Nadim MK, Garcia­‑Tsao G. Acute Kidney Injury in Patients with Cirrhosis. N Engl J Med. 2023;388:733-45. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.